BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 38445632)

  • 1. Biological determinants of radioresistance and their remediation in pancreatic cancer.
    Seshacharyulu P; Baine MJ; Souchek JJ; Menning M; Kaur S; Yan Y; Ouellette MM; Jain M; Lin C; Batra SK
    Biochim Biophys Acta Rev Cancer; 2017 Aug; 1868(1):69-92. PubMed ID: 28249796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Understanding the molecular mechanism responsible for developing therapeutic radiation-induced radioresistance of rectal cancer and improving the clinical outcomes of radiotherapy - A review.
    Jain SM; Nagainallur Ravichandran S; Murali Kumar M; Banerjee A; Sun-Zhang A; Zhang H; Pathak R; Sun XF; Pathak S
    Cancer Biol Ther; 2024 Dec; 25(1):2317999. PubMed ID: 38445632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. XRCC2 as a predictive biomarker for radioresistance in locally advanced rectal cancer patients undergoing preoperative radiotherapy.
    Qin CJ; Song XM; Chen ZH; Ren XQ; Xu KW; Jing H; He YL
    Oncotarget; 2015 Oct; 6(31):32193-204. PubMed ID: 26320178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of nuclear β-catenin in rectal adenocarcinoma is associated with radioresistance.
    Wang L; Zhang XM; Li Z; Liu XJ; Chai J; Zhang GY; Cheng YF
    World J Gastroenterol; 2013 Oct; 19(40):6876-82. PubMed ID: 24187464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CSC Radioresistance: A Therapeutic Challenge to Improve Radiotherapy Effectiveness in Cancer.
    Olivares-Urbano MA; Griñán-Lisón C; Marchal JA; Núñez MI
    Cells; 2020 Jul; 9(7):. PubMed ID: 32660072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypoxia Modulates Radiosensitivity and Response to Different Radiation Qualities in A549 Non-Small Cell Lung Cancer (NSCLC) Cells.
    Nisar H; Labonté FM; Roggan MD; Schmitz C; Chevalier F; Konda B; Diegeler S; Baumstark-Khan C; Hellweg CE
    Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38256084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting PI3K/Akt/mTOR signaling pathway in the treatment of prostate cancer radioresistance.
    Chang L; Graham PH; Ni J; Hao J; Bucci J; Cozzi PJ; Li Y
    Crit Rev Oncol Hematol; 2015 Dec; 96(3):507-17. PubMed ID: 26253360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Role of Macrophages in the Pathogenesis of Atherosclerosis.
    Blagov AV; Markin AM; Bogatyreva AI; Tolstik TV; Sukhorukov VN; Orekhov AN
    Cells; 2023 Feb; 12(4):. PubMed ID: 36831189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. KCNE4 expression is correlated with the pathological characteristics of colorectal cancer patients and associated with the radioresistance of cancer cells.
    Tian K; Tao Z; Chen Y; Du J; Chen M; Wang D; Li Z
    Pathol Res Pract; 2023 Jan; 241():154234. PubMed ID: 36459833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytotoxic and Radiosensitizing Effects of Folic Acid-Conjugated Gold Nanoparticles and Doxorubicin on Colorectal Cancer Cells.
    Heshmatian B; Behrouzkia Z; Mohammadian M; Moradi Z; Mohammadi Z; Zohdi Aghdam R
    Adv Pharm Bull; 2022 Aug; 12(4):772-779. PubMed ID: 36415636
    [No Abstract]   [Full Text] [Related]  

  • 11. JNC-1043, a Novel Podophyllotoxin Derivative, Exerts Anticancer Drug and Radiosensitizer Effects in Colorectal Cancer Cells.
    Kwon JH; Lee NG; Kang AR; Ahn IH; Choi IY; Song JY; Hwang SG; Um HD; Choi JR; Kim J; Park JK
    Molecules; 2022 Oct; 27(20):. PubMed ID: 36296600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of Phosphoglycerate Dehydrogenase Radiosensitizes Human Colorectal Cancer Cells under Hypoxic Conditions.
    Van de Gucht M; Dufait I; Kerkhove L; Corbet C; de Mey S; Jiang H; Law KL; Gevaert T; Feron O; De Ridder M
    Cancers (Basel); 2022 Oct; 14(20):. PubMed ID: 36291844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PI3K/Akt/mTOR signaling pathway in cancer stem cells.
    Karami Fath M; Ebrahimi M; Nourbakhsh E; Zia Hazara A; Mirzaei A; Shafieyari S; Salehi A; Hoseinzadeh M; Payandeh Z; Barati G
    Pathol Res Pract; 2022 Sep; 237():154010. PubMed ID: 35843034
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.